Icon plc Aktie
295,60 €
Deine Einschätzung
Icon plc Aktie
Was spricht für und gegen Icon plc in den nächsten Jahren?
Pro
Kontra
Rendite von Icon plc im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Icon plc | -1,20 % | 0,85 % | 6,19 % | 44,18 % | 15,40 % | - | - |
Alkermes plc | 0,94 % | -3,60 % | -2,73 % | -21,90 % | -14,40 % | 13,23 % | 9,18 % |
Ironwood Pharmaceuticals | 5,45 % | 6,42 % | -24,68 % | -43,14 % | -43,14 % | -38,95 % | - |
Novocure Ltd | 7,10 % | -4,92 % | 53,48 % | -72,68 % | 42,14 % | -87,76 % | - |
Kommentare
News
ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance
ICON plc, (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, will host its 2024 Investor Day today in New York City. The event will feature presentations
ICON plc to hold Investor Day Meeting on May 30, 2024
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that it will hold an Investor Day which will take place on Thursday, May 30
ICON releases its ICON Cares 2023 Report
ICON plc, (NASDAQ:ICLR) a world-leading healthcare intelligence and clinical research organisation, today releases its ICON Cares 2023 Report. This outlines how the company is delivering on its